Racial differences in glycemic markers: A cross-sectional analysis of community-based data

Annals of Internal Medicine

Volumn 154, Issue 5, 2011, Pages 303-309

  Selvin, Elizabeth ^a   Steffes, Michael W ^b   Ballantyne, Christie M ^c   Hoogeveen, Ron C ^c   Coresh, Josef ^a   Brancati, Frederick L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

AGED; ARTICLE; DIABETES MELLITUS; DIET RESTRICTION; ERYTHROCYTE; FEMALE; GLUCOSURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 79952229368     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-154-5-201103010-00004     Document Type: Article

References (39)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1:S62-9. [PMID: 20042775]
2. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, et al; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007;30:2453-7. [PMID: 17536077]
3. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32: 1327-34. [PMID: 19502545]
4. Herman WH, Dungan KM, Wolffenbuttel BH, Buse JB, Fahrbach JL, Jiang H, et al. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94:1689-94. [PMID: 19276235]
5. Cohen RM. A1C: does one size fit all? [Editorial]. Diabetes Care. 2007;30: 2756-8. [PMID: 17901536]
6. Olabi B, Bhopal R. Diagnosis of diabetes using the oral glucose tolerance test [Editorial]. BMJ. 2009;339:b4354. [PMID: 19864355]
7. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS. Distribution and cardiovascular risk correlates of hemoglobin A(1c) in nondiabetic younger adults: the Bogalusa Heart Study. Metabolism. 2008;57:1487-92. [PMID: 18940383]
8. Saaddine JB, Fagot-Campagna A, Rolka D, Narayan KM, Geiss L, Eberhardt M, et al. Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care. 2002;25:1326-30. [PMID: 12145229]
9. Fagot-Campagna A, Saaddine JB, Flegal KM, Beckles GL; Third National Health and Nutrition Examination Survey. Diabetes, impaired fasting glucose, and elevated HbA1c in U.S. adolescents: the Third National Health and Nutrition Examination Survey. Diabetes Care. 2001;24:834-7. [PMID: 11347739]
10. Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L. Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study. Diabetologia. 1989;32:864-9. [PMID: 2693166]
11. Kamps JL, Hempe JM, Chalew SA. Racial disparity in A1C independent of mean blood glucose in children with type 1 diabetes. Diabetes Care. 2010;33: 1025-7. [PMID: 20185743]
12. Herman WH, Cohen RM. Hemoglobin A1c: teaching a new dog old tricks [Editorial]. Ann Intern Med. 2010;152:815-7. [PMID: 20547908]
13. Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152:770-7.[PMID: 20547905]
14. Dagogo-Jack S. Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum. Nat Rev Endocrinol. 2010;6:589-93. [PMID: 20680035]
15. Bloomgarden ZT. A1C: recommendations, debates, and questions. Diabetes Care. 2009;32:e141-7. [PMID: 19940210]
16. Gama R, Likhari T. Diagnosis of diabetes. Haemoglobin A1c: ethnic differences apply to the UK [Letter]. BMJ. 2009;339:b5648. [PMID: 20044400]
17. Eldeirawi K, Lipton RB. Predictors of hemoglobin A1c in a national sample of nondiabetic children: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2003;157:624-32. [PMID: 12672682]
18. Kirk JK, D'Agostino RB Jr, Bell RA, Passmore LV, Bonds DE, Karter AJ, et al. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care. 2006;29:2130-6.[PMID: 16936167]
19. Selvin E, Zhu H, Brancati FL. Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care. 2009;32:828-33.[PMID: 19196895]
20. Kirk JK, Passmore LV, Bell RA, Narayan KM, D'Agostino RB Jr, Arcury TA, et al. Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care. 2008;31:240-6. [PMID: 17977939]
21. Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff DC Jr, et al. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother. 2005;39:1489-501.[PMID: 16076917]
22. Brown AF, Gregg EW, Stevens MR, Karter AJ, Weinberger M, Safford MM, et al. Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2005;28:2864-70. [PMID: 16306546]
23. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, et al; ADAG Study Group. Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study. Diabetes. 2010;59: 1585-90. [PMID: 20424232]
24. Buse JB, Freeman JL, Edelman SV, Jovanovic L, McGill JB. Serum 1,5-anhydroglucitol (GlycoMark): a short-term glycemic marker. Diabetes Technol Ther. 2003;5:355-63. [PMID: 12828817]
25. Yamanouchi T, Minoda S, Yabuuchi M, Akanuma Y, Akanuma H, Miyashita H, et al. Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients. Diabetes. 1989;38:723-9. [PMID: 2656341]
26. True MW. Circulating biomarkers of glycemia in diabetes management and implications for personalized medicine. J Diabetes Sci Technol. 2009;3:743-7. [PMID: 20144323]
27. Pal A, Farmer AJ, Dudley C, Selwood MP, Barrow BA, Klyne R, et al. Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes. Diabetes Care. 2010;33:252-7. [PMID: 19933992]
28. Suwa T, Ohta A, Matsui T, Koganei R, Kato H, Kawata T, et al. Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J. 2010;57:135-40. [PMID: 19926921]
29. Won JC, Park CY, Park HS, Kim JH, Choi ES, Rhee EJ, et al. 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. Diabetes Res Clin Pract. 2009;84:51-7. [PMID: 19187997]
30. Stettler C, Stahl M, Allemann S, Diem P, Schmidlin K, Zwahlen M, et al. Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes Care. 2008;31:1534-5. [PMID: 18426859]
31. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129:687-702. [PMID: 2646917]
32. Jackson R, Chambless LE, Yang K, Byrne T, Watson R, Folsom A, et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. J Clin Epidemiol. 1996;49:1441-46.[PMID: 8970495]
33. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol. 1996;49:223-33. [PMID: 8606324]
34. Wagenknecht L, Wasserman B, Chambless L, Coresh J, Folsom A, Mosley T, et al. Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Imaging. 2009;2:314-22. [PMID: 19808612]
35. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800-11. [PMID: 20200384]
36. Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes. 2010;60:298-305. [PMID: 20978092]
37. Viberti G, Lachin J, Holman R, Zinman B, Haffner S, Kravitz B, et al; for the ADOPT Study Group. A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe. Diabet Med. 2006;23:1289-94. [PMID: 17116177]
38. Hu Y, Block G, Sternfeld B, Sowers M. Dietary glycemic load, glycemic index, and associated factors in a multiethnic cohort of midlife women. J Am Coll Nutr. 2009;28:636-47. [PMID: 20516263]
39. Stevens J, Ahn K, Juhaeri, Houston D, Steffan L, Couper D. Dietary fiber intake and glycemic index and incidence of diabetes in African-American and white adults: the ARIC study. Diabetes Care. 2002;25:1715-21. [PMID: 12351467]